Rutger van der Schrier

4PUBLICATIONS
16CO-AUTHORS
Molecular targetsToxicology (incl. clinical toxicology)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 14, 2026
Targeting the Carotid Body Function With Big-K+-Channel Blocker ENA-001 in Opioid-Induced Respiratory Depression: A Scoping Review.

|Mar 18, 2026
Effect of Paroxetine or Escitalopram Coadministered with Oxycodone versus Oxycodone Alone on Ventilation during Hypercapnia: A Randomized Clinical Trial.

Jeffry Florian, Dro Keshishi, Victoria Gershuny

|Feb 05, 2026
Intranasal Naloxone Reversal of Opioid-induced Respiratory Depression in Opioid-naive Individuals and Self-reported Daily Opioid Users.

Maarten A van Lemmen, Jeffry Florian, Zhihua Li

|May 19, 2025
A comparison of intramuscular (Zimhi) and intranasal naloxone (Narcan) in reversal of fentanyl-induced apnea: a randomized, crossover, open-label trial.

Maarten A van Lemmen, Monique van Velzen, Elise Y Sarton

Pageof 1

Frequent Collaborators

3 joint publications

Maarten van Lemmen

3 joint publications

Albert Dahan

2 joint publications

Monique van Velzen

1 joint publications

Jimmy J Arevalo